Review: 7-day proton-pump inhibitor-based triple therapy is as effective as > 7 days of the same regimen for heading H. pylori--associated peptic ulcer

Zanten, Sunder Veldhuyzen van
September 2005
ACP Journal Club;Sep/Oct2005, Vol. 143 Issue 2, p49
Academic Journal
The article presents a study that compares the efficacy of 7-day proton-pump inhibitor-based triple therapy regimen with regimen of more than seven days of the same regimen for healing the peptic ulcer. Researchers analyzed controlled trials in any language except Japanese that endoscopically documented the presence of ulcer and compared a 7-day combination of a PPI plus 2 antibiotics with the same regimen. PPI prolonged for more than 7 days to cure Heliobacter pylori and to heal peptic ulcer disease.


Related Articles

  • Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update. Wedemeyer, Ralph-Steven; Blume, Henning // Drug Safety;Apr2014, Vol. 37 Issue 4, p201 

    Proton pump inhibitors (PPIs) are used extensively for the treatment of gastric acid-related disorders, often over the long term, which raises the potential for clinically significant drug interactions in patients receiving concomitant medications. These drug-drug interactions have been...

  • Helicobacter pylori Gastritis in Children - Assessment of Resistance to Treatment on the Casuistry of the 1st Pediatric Clinic Tîrgu MureÅŸ. Oana, Mărginean; Ana-Maria, Pitea; Klara, Brînzaniuc // Acta Medica Marisiensis;Oct2011, Vol. 57 Issue 5, p487 

    Background: It is generally recognized the role of Helicobacter pylori in the pathogenesis of peptic ulcer disease in adults and children. Some cases raise serious concern regarding the therapeutic approach because they do not heal with normal treatment schemes or have frequent relapses due to...

  • Peptic ulcer recurrence during maintenance therapy with H[sub 2] -receptor antagonist following first-line therapy with proton pump inhibitor. Kaneko, Eizo; Hoshihara, Yoshio; Sakaki, Nobuhiro; Harasawa, Shigeru; Ashida, Kiyoshi; Asaka, Masahiro; Asaki, Shigeru; Nakamura, Takashi; Kobayashi, Kenzo; Kajiyama, Goro; Ogawa, Nobuya; Yao, Tsuneyoshi; Muto, Yasutoshi; Nakazawa, Saburo; Takemoto, Tadayoshi // Journal of Gastroenterology;2000, Vol. 35 Issue 11, p824 

    Abstract: We investigated the peptic ulcer recurrence rates during maintenance therapy with H[sub 2]-receptor antagonists (H[sub 2]RAs) following first-line therapy with a proton pump inhibitor (PPI). Patients with gastric ulcer (GU) or duodenal ulcer (DU) were enrolled in this study; 583...

  • Effect of Rebamipide on Quality of Peptic Ulcer Healing in Rat. Zhu Qi; Li Jie; Cao Haixia; Zhao Xiaoying // Digestive Diseases & Sciences;Sep2009, Vol. 54 Issue 9, p1876 

    The aim of this study is to elucidate the effects and the mechanism of rebamipide, omeprazole, and their combination treatment on quality of peptic ulcer healing (QOUH). Peptic ulcer models were induced by acetic acid exposure of the serosa of rat stomach. Forty Sprague-Dawley (SD) rats were...

  • H. PYLORI ERADICATION OPTIONS FOR PEPTIC ULCER DISEASE.  // Monthly Prescribing Reference;Oct2013, Vol. 29 Issue 10, p134 

    A table is presented which lists several therapeutic drugs for the treatment of peptic ulcer disease which include the Helidac as combination therapy, the nizatidine as antagonist-based treatment and the Nexium as proton pump inhibitor-based treatment.

  • Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.  // Journal of Infection in Developing Countries;Nov2010, Vol. 4 Issue 11, p712 

    No abstract available.

  • Safety and Efficacy of Rabeprazole in Combination With Four Antibiotic Regimens for the Eradication of Helicobacter pylori in Patients With Chronic Gastritis With or Without Peptic Ulceration. Stack, W. A.; Knifton, A.; Thirlwell, D.; Cockayne, A.; Jenkins, D.; Hawkey, C. J.; Atherton, J. C. // American Journal of Gastroenterology;Oct1998, Vol. 93 Issue 10, p1909 

    Objectives: Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis. The aim of this study was to evaluate rabeprazole in combination with antibiotics for the eradication of Helicobacter...

  • Herbal Drugs With Anti Ulcer Activity. Kaur, Dilpreet; Rana, A. C.; Sharma, Nidhi; Kumar, Sunil // Journal of Applied Pharmaceutical Science;2012, Vol. 2 Issue 3, p160 

    A peptic ulcer is an erosion in a segment of the gastro intestinal mucosa, typically in the stomach (gastric ulcer) or first few centimeters of duodenum (duodenal ulcer) that penetrates through the muscularis mucosae. Contrary to popular belief, ulcer is not caused by spicy food but instead is...

  • RECENT TRENDS OF TREATMENT AND MEDICATION PEPTIC ULCERATIVE DISORDER. Bhowmik, Debjit; Tripathi, K. K.; Sampath Kumar, K. P. // International Journal of PharmTech Research;Jan-Mar2010, Vol. 2 Issue 1, p970 

    Most peptic ulcers can be healed with proper treatment. Research has found that the majority of peptic ulcers are caused by an infection with a bacterium called Helicobacter pylori (H. pylori), and standard treatment in these cases is a combination of drugs, including antibiotics and a proton...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics